A carregar...

The discovery and development of belimumab: the anti-BLyS–lupus connection

For the first time in more than 50 years, the US Food and Drug Administration has approved a drug specifically for the treatment of systemic lupus erythematosus (SLE). This drug, belimumab (Benlysta), is a human monoclonal antibody that neutralizes the B-cell survival factor, B-lymphocyte stimulator...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stohl, William, Hilbert, David M
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3264947/
https://ncbi.nlm.nih.gov/pubmed/22231104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.2076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!